Search for:
Author

Baker McKenzie

Browsing

Please direct any comments or queries regarding this post to Editors@bakermckenzie.com.

On 24 May 2022, the bill on ‘Transparency rules on relationships between manufacturing companies, healthcare professionals and organizations’ (“Sunshine Act”) was finally approved. The Sunshine Act will enter into force after its publication in the Official Gazette.

On 16 February 2022, the Medical Device Coordination Group approved a new document to provide guidance to Notified Bodies on the appropriate way to carry out surveillance activities on CE-marked devices in accordance with the Medical Devices Directive 93/42/EEC and the Active Implantable Medical Devices Directive 90/385/EEC, which, by virtue of the provisions of Article 120(3) of Regulation EU 745/2014, can be marketed until 26 May 2024.

On 6 May 2022, the OECD released a public consultation document with respect to the Regulated Financial Services Exclusion for Amount A. This latest consultation document follows four other publications on aspects of Amount A since February relating to nexus and revenue sourcing, tax base determinations, scope, and the extractives exclusion. As with earlier draft model rules, this publication is a work-in-progress and subject to changes. The OECD welcomes comments from the public before 20 May 2022, following which a more detailed commentary on a number of technical items is expected to be released.

Baker McKenzie’s Sanctions Blog published the alert titled New Russian legal framework for blocking sanctions prohibiting: (i) Russian persons from entering transactions with designated persons; and (ii) the export of certain Russian items in favour of sanctioned persons on 4 May 2022. Read the article via the link here. Please also visit our Sanctions Blog for the most recent updates.